Cardiorenal syndromes

Current Opinion in Critical Care

Volumn 15, Issue 5, 2009, Pages 384-391

  Ronco, Claudio ^a   Cruza, Dinna N ^a   Ronco, Federico ^b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Acute heart failure; Acute kidney injury; Cardiorenal syndrome; Cardiovascular risk; Chronic kidney disease; Heart kidney interaction; Renocardiac syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; FUROSEMIDE; LOOP DIURETIC AGENT; SOTALOL; VASODILATOR AGENT; VASOPRESSIN RECEPTOR ANTAGONIST;

ACUTE CARDIORENAL SYNDROME; ACUTE DISEASE; ACUTE HEART FAILURE; ACUTE RENOCARDIAC SYNDROME; ANEMIA; CARDIOVASCULAR RISK; CHRONIC CARDIORENAL SYNDROME; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC RENOCARDIAC SYNDROME; CLINICAL FEATURE; DISEASE CLASSIFICATION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; EARLY DIAGNOSIS; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HUMAN; KIDNEY DYSFUNCTION; PATHOPHYSIOLOGY; REVIEW; SECONDARY CARDIORENAL SYNDROME; SYMPTOM;

ACUTE DISEASE; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HEART DISEASES; HUMANS; KIDNEY DISEASES; SYNDROME;

EID: 70350117991     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32832e971b     Document Type: Review

References (50)

1. Dar O, Cowie MR. Acute heart failure in the intensive care unit: epidemiology. Crit Care Med 2008; 36 (1 Suppl):S3-S8.
2. Ronco C. Cardiorenal and reno-cardiac syndromes: clinical disorders in search of a systematic definition. Int J Artif Organs 2008; 31:1-2. This editorial describes for the first time the concept of cardiorenal and renocardiac interactions.
3. Liang KV, Williams AW, Greene EL, Redfield MM. Acute decompensated heart failure and the cardio-renal syndrome. Crit Care Med 2008; 36 (Suppl):S75-S88.
4. Ronco C, House AA, Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med 2008; 34:957-962. This is the first approach to a systematic definition of the CRS.
5. Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52:1527-1539. This is the seminal study that described the new classification of the CRS and initiated the process of consensus for the modern classification.
6. European Society of Cardiology; Heart Failure Association of the ESC (HFA); European Society of Intensive Care Medicine (ESICM), Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10:933-989. This study represents the basis for the modern definition and approach to heart failure.
7. Mebazaa A, Gheorghiade M, Pina IL, et al. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med 2008; 36 (Suppl):S129-S139.
8. Bellomo R, Ronco C, Kellum JA, et al., and the ADQI workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the ADQI Group. Crit Care 2004; 8:R204-R212.
9. Adams KF, Fonarow GC, Emerman CL, et al. Characteristics and outcome of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149:209-216.
10. Fonarow GC, Gattis Stough W, Abraham WT, et al. Characteristics, treatments and outcomes of patients with preserved systolic function hospitalized for heart failure. J Am Coll Cardiol 2007; 50:768-777.
11. Jose P, Skali H, Anavekar N, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 2006; 17:2886-2891.
12. Goldberg A, Hammerman H, Petcherski S, et al. In-hospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 2005; 150:330-337.
13. Tokuyama H, Kelly DJ, Zhang Y, et al. Macrophage infiltration and cellular proliferation in the nonischemic kidney and heart following prolonged unilateral renal ischemia. Nephron Physiol 2007; 106:54-62.
14. Almeshari K, Ahlstrom NG, Capraro FE, et al. A volume independent component to post diuretic sodium retention in humans. J Am Soc Nephrol 1993;102:450-458.
15. Howard PA, Dunn MI. Aggressive diuresis for severe heart failure in the elderly. Chest 2001; 119:807-810.
16. Opdam H, Wan L, Bellomo R. A pilot assessment of the FloTrac cardiac output monitoring system. Intensive Care Med 2007; 133:344-349.
17. Mayer J, Boldt J, Wolf MW, et al. Cardiac output derived from arterial pressure waveform analysis in patients undergoing cardiac surgery. Validity of a second generation device. Anesth Analg 2008; 106:867-872.
18. Wan L, Naka T, Uchino S, Bellomo R. A pilot study of pulse contour cardiac output monitoring in patients with septic shock. Crit Care Resusc 2005;7:165-169.
19. Nguyen BH, Losey T, Rasmussen BA, et al. Interrater reliability of cardiac output measurements by transcutaneous Doppler ultrasound: implications for noninvasive hemodynamic monitoring in the ED. Am J Emerg Med 2006;24:828-835.
20. Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49:675-683.
21. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: a randomized placebocontrolled trial. Lancet 2005; 366:1622-1632.
22. Yorgun H, Deniz A, Aytemir K. Cardiogenic shock secondary to combination of diltiazem and sotalol. Intern Med J 2008; 38:221-222.
23. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355:260-269.
24. Jie KE, Verhaar MC, Cramer MJ, et al. Erythropoietin and the cardio-renal syndrome: cellular mechanisms on the cardio-renal connectors. Am J Physiol Renal Physiol 2006; 291:F932-F944.
25. Palazzuoli A, Silverberg DS, Iovine F, et al. Effects of beta-erythropoietin treatment of left ventricular remodelling, systolic function, and B-type natriuretic peptide levels in patients with the cardio-renal anemia syndrome. Am Heart J 2007; 154:e9-e15.
26. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004; 147:331-339.
27. McCullough PA. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med 2002; 3:71-76.
28. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002; 137:563-570.
29. Beattie JN, Soman SS, Sandberg KR, et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001; 37:1191-1200.
30. Gibson CM, Pinto DS, Murphy SA, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 2003; 42:1535-1543.
31. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensinconverting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003; 42:201-208.
32. French WJ, Wright RS. Renal insufficiency and worsened prognosis with STEMI: a call for action. J Am Coll Cardiol 2003; 42:1544-1546.
33. Levin A, Foley RN. Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 2000; 36 (6 Suppl 3):S24-S30.
34. Ruggenenti P, Perna A, Remuzzi G. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am Soc Nephrol 2001; 12:2832-2837.
35. Fung JW, Szeto CC, Cahn JY, et al. Prognostic value of renal function in patients with cardiac resynchronization therapy. In J Cardiol 2007; 122:10-16.
36. Gheorghiade M, Niazi I, Ouyang J, et al. Vasorpessin-V-2 receptor blockade with tolvaptan in patients with chronic heart failure: results of a double-blind randomized trial. Circulation 2003; 107:2690-2696.
37. Konstan MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 2007; 297:1319-1331.
38. Uchino S, Bellomo R, Goldsmith D, Bates S. An assessment of the RIFLE criteria for ARF in hospitalized patients. Crit Care Med 2006; 34:1913-1917.
39. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int 2008; 73:538-546.
40. Bagshaw SM, George C, Dinu I, Bellomo R. A multicenter evaluation of the RIFLE criteria of early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23:1203-1210. (Pubitemid 351767483)
41. Blake P, Hasegawa Y, Khosla MC, et al. Isolation of myocardial depressant factor(s) from the ultrafiltrate of heart failure patients with acute renal failure. ASAIO J 1996; 42:M911-M915.
42. Meyer TW, Hostetter TH. Uremia N Engl J Med 2007; 357:1316-1325.
43. Figueras J, Stein L, Diez V, et al. Relationship between pulmonary hemodynamics and arterial pH and carbon dioxide tension in critically ill patients. Chest 1976; 70:466-472.
44. Brady JP, Hasbargen JA. A review of the effects of acidosis on nutrition in dialysis patients. Semin Dial 2000; 13:252-255.
45. McCullough PA, Sandberg KR. Chronic kidney disease and sudden death: strategies for prevention. Blood Purif 2004; 22:136-142.
46. Selby NM, McIntyre CW. The acute cardiac effects of dialysis. Semin Dial 2007; 20:220-228.
47. Ronco C, Bellomo R, Ricci Z. Continuous renal replacement therapy in the critically ill patients. Nephrol Dial Transplant 2001; 16 (Suppl):67-72. (Pubitemid 32750433)
48. Chertow GM, Normand SL, Silva LR, McNeil BJ. Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project. Am J Kidney Dis 2000; 35:1044-1051.
49. Cunningham PN, Dyanov HM, Park P, et al. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF-1 receptors in kidney. J Immunol 2007; 168:5817-5823.
50. Kumar A, Paladugu B, Mensing J, et al. Nitric oxide-dependent and independent mechanisms are involved in TNF-alpha induced depression of cardiac myocyte contractility. Am J Physiol Regul Integr Comp Physiol 2007;292:R1900-R1906.